|
2021-22 Evaluation_Hematology Conference |
07/01/2021 - 7:00am EDT to 06/30/2022 - 6:00pm EDT |
|
Hematology Conference 2021-22 "Treatment of High Risk Myeloma" |
01/26/2022 - 8:00am to 9:00am EST |
|
Hematology Conference 2021-22 "Treatment of High Risk Myeloma" - MOC - ABPath |
01/26/2022 - 8:00am to 9:00am EST |
|
Hematology Conference 2021-22 "Treatment of High Risk Myeloma" - MOC - ABIM II |
01/26/2022 - 8:00am to 9:00am EST |
|
Hematology Conference 2021-22 "DLI" |
02/23/2022 - 8:00am to 9:00am EST |
|
Hematology Conference 2021-22 "DLI" - MOC - ABPath |
02/23/2022 - 8:00am to 9:00am EST |
|
Hematology Conference 2021-22 "DLI" - MOC - ABIM II |
02/23/2022 - 8:00am to 9:00am EST |
|
Hematology Conference 2021-22 "Anaplastic Large Cell Lymphoma ( ALCL)" |
03/23/2022 - 8:00am to 9:00am EDT |
|
Hematology Conference 2021-22 "Anaplastic Large Cell Lymphoma ( ALCL)" - MOC - ABIM II |
03/23/2022 - 8:00am to 9:00am EDT |
|
Hematology Conference 2021-22 "Anaplastic Large Cell Lymphoma ( ALCL)" - MOC - ABPath |
03/23/2022 - 8:00am to 9:00am EDT |